Literature DB >> 15252431

The attitudes and beliefs of oncology nurse practitioners regarding direct-to-consumer advertising of prescription medications.

Pamela Hallquist Viale1, Deanna Sanchez Yamamoto.   

Abstract

PURPOSE/
OBJECTIVES: To obtain information about the knowledge and attitudes of oncology nurse practitioners (ONPs) concerning the effect of direct-to-consumer (DTC) advertising of prescription medications on prescribing patterns.
DESIGN: Exploratory survey.
SETTING: Oncology Nursing Society Nurse Practitioner Special Interest Group members in the United States. SAMPLE: 221 of 376 ONPs completed the survey (58%).
METHODS: Researcher-developed 12-question postal survey. MAIN RESEARCH VARIABLES: Knowledge and attitudes of ONPs on DTC advertising effects on prescribing patterns.
FINDINGS: The findings were similar to those of previous studies of physicians regarding the number of visits when patients requested DTC-advertised medications. Major differences were the positive attitudes of ONPs toward potentially longer patient visits to explain and educate patients regarding medication requests based on DTC advertising and smaller percentages of ONPs who felt "pressured" to prescribe requested medications.
CONCLUSIONS: ONPs have mixed opinions regarding the practice of DTC advertising but do not believe that they are influenced heavily by advertising with regard to prescriptive practices. ONPs consider patient encounters for education purposes as appropriate and include information about requested DTC-advertised medications in their approach to patient care. IMPLICATIONS FOR NURSING: This is an exploratory survey of a specialty group of ONPs. More research is needed to further explore the practice of DTC advertising and potential influences on the prescribing patterns of ONPs. DTC advertising of prescription medications is increasing; ONPs need to increase their knowledge base about the potential for influences of prescriptive practices.

Entities:  

Mesh:

Year:  2004        PMID: 15252431     DOI: 10.1188/04.ONF.777-783

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  8 in total

1.  Update on Direct-to-Consumer Marketing in Oncology.

Authors:  Stacy W Gray; Gregory A Abel
Journal:  J Oncol Pract       Date:  2012-02-21       Impact factor: 3.840

2.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

3.  Quantitative Information on Oncology Prescription Drug Websites.

Authors:  Helen W Sullivan; Kathryn J Aikin; Linda B Squiers
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

4.  Ethical and epistemic issues in direct-to-consumer drug advertising: where is patient agency?

Authors:  Catherine A Womack
Journal:  Med Health Care Philos       Date:  2013-05

5.  Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.

Authors:  Gregory A Abel; Harold J Burstein; Nathanael D Hevelone; Jane C Weeks
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

Review 6.  Consumer empowerment in dermatology.

Authors:  Heather E Hoch; Kristine L Busse; Robert P Dellavalle
Journal:  Dermatol Clin       Date:  2009-04       Impact factor: 3.478

Review 7.  Soft targets: nurses and the pharmaceutical industry.

Authors:  Annemarie Jutel; David B Menkes
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069

8.  A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.

Authors:  Young-Mo Yang; Jae-Joon Lee; Eun Jeong; Sun Young Kim; Mi Ah Han; Eun Joo Choi
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.